A Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN) Diabetes Trial is a "Dud"
6/19/2013 7:07:22 AM
More...
|
Bristol-Myers Squibb Company (BMY) Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based Careers
6/18/2013 9:24:45 AM
More...
|
Positive Survival Data for Bristol-Myers Squibb Company (BMY)/AbbVie (ABBV)'s Blood Cancer Drug
6/17/2013 6:59:30 AM
More...
|
Bristol-Myers Squibb Company (BMY), Simcere Pharmaceutical Group Form Pact for Development of RA Treatment
6/14/2013 7:14:42 AM
More...
|
Former Bristol-Myers Squibb Company (BMY) Executive Admits to Insider Trading
6/11/2013 6:54:26 AM
More...
|
Bristol-Myers Squibb Company (BMY) to Take Part in Goldman, Sachs & Co. Global Healthcare Conference
6/6/2013 6:42:58 AM
More...
|
Bristol-Myers Squibb Company (BMY) Coupons for Abilify are Not Bribes: Judge
6/5/2013 7:38:00 AM
More...
|
FDA Grants Priority Review to Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN)’s Metreleptin, an Investigational Agent for Treatment of Metabolic Disorders Associated With Rare Forms of Lipodystrophy
6/4/2013 10:11:27 AM
More...
|
Bristol-Myers Squibb Company (BMY) Announces Phase 1 Results From First Trial Combining Immune Checkpoint Inhibitors, Investigational Agent Nivolumab and Yervoy® (ipilimumab), in Patients With Advanced Melanoma
6/3/2013 10:38:06 AM
More...
|
Johnson & Johnson (JNJ): We're Creaming Medivation, Inc. (MDVN), Boehringer Ingelheim Corporation, Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE)
5/24/2013 8:32:02 AM
More...
|
|